| Product Code: ETC8199303 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of Malta patient-derived xenograft (PDX) models in 2024 continued to show a high level of concentration, with the top exporting countries being Italy, Canada, UK, USA, and China. The Herfindahl-Hirschman Index (HHI) remained at a high level, indicating a concentrated market. The compound annual growth rate (CAGR) from 2020 to 2024 was moderate at 2.61%, while the growth rate from 2023 to 2024 spiked significantly at 262.55%. This data suggests a dynamic and rapidly evolving market for PDX models in Malta, with potential opportunities for further growth and development in the future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Patient Derived Xenograft (PDX) Models Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, 2022 & 2032F |
3.3 Malta Patient Derived Xenograft (PDX) Models Market - Industry Life Cycle |
3.4 Malta Patient Derived Xenograft (PDX) Models Market - Porter's Five Forces |
3.5 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Tumor Type, 2022 & 2032F |
3.7 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Technique, 2022 & 2032F |
3.9 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Malta Patient Derived Xenograft (PDX) Models Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Rising demand for personalized medicine and targeted therapies |
4.2.2 Increasing prevalence of cancer and the need for more effective treatment options |
4.2.3 Growing focus on precision medicine and drug development |
4.3 Market Restraints |
4.3.1 High cost associated with the development and maintenance of patient-derived xenograft (PDX) models |
4.3.2 Ethical concerns related to the use of animals in research |
4.3.3 Limited availability of suitable tumor samples for PDX model creation |
5 Malta Patient Derived Xenograft (PDX) Models Market Trends |
6 Malta Patient Derived Xenograft (PDX) Models Market, By Types |
6.1 Malta Patient Derived Xenograft (PDX) Models Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Mice Models, 2022 - 2032F |
6.1.4 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Rat Models, 2022 - 2032F |
6.2 Malta Patient Derived Xenograft (PDX) Models Market, By Tumor Type |
6.2.1 Overview and Analysis |
6.2.2 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Gastrointestinal Tumor Models, 2022 - 2032F |
6.2.3 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Lung Tumor Models, 2022 - 2032F |
6.2.4 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Haematological Tumor Models, 2022 - 2032F |
6.3 Malta Patient Derived Xenograft (PDX) Models Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Preclinical Drug Development, 2022 - 2032F |
6.3.3 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Precision Medicine, 2022 - 2032F |
6.3.4 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Co-Clinical Trials, 2022 - 2032F |
6.3.5 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Basic Cancer Research, 2022 - 2032F |
6.3.6 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Biomarker Analysis, 2022 - 2032F |
6.3.7 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Oncology Research, 2022 - 2032F |
6.4 Malta Patient Derived Xenograft (PDX) Models Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Heterotopic Implantation, 2022 - 2032F |
6.4.3 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Orthotropic Implantation, 2022 - 2032F |
6.5 Malta Patient Derived Xenograft (PDX) Models Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Academic and Research Organizations, 2022 - 2032F |
6.5.3 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Contract Research Organizations, 2022 - 2032F |
6.5.4 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Pharmaceutical and Biotechnological Companies, 2022 - 2032F |
6.5.5 Malta Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Others, 2022 - 2032F |
7 Malta Patient Derived Xenograft (PDX) Models Market Import-Export Trade Statistics |
7.1 Malta Patient Derived Xenograft (PDX) Models Market Export to Major Countries |
7.2 Malta Patient Derived Xenograft (PDX) Models Market Imports from Major Countries |
8 Malta Patient Derived Xenograft (PDX) Models Market Key Performance Indicators |
8.1 Average time taken to establish a PDX model |
8.2 Success rate of engraftment of patient tumor samples in PDX models |
8.3 Number of collaborations between research institutions and pharmaceutical companies for PDX model development |
9 Malta Patient Derived Xenograft (PDX) Models Market - Opportunity Assessment |
9.1 Malta Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Malta Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Tumor Type, 2022 & 2032F |
9.3 Malta Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Malta Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Technique, 2022 & 2032F |
9.5 Malta Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Malta Patient Derived Xenograft (PDX) Models Market - Competitive Landscape |
10.1 Malta Patient Derived Xenograft (PDX) Models Market Revenue Share, By Companies, 2025 |
10.2 Malta Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here